Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Stemline Therapeutics
Stemline Therapeutics
(STML)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Elzonris
Tagraxofusp
2018-12-21
Lymphoma
,
Malignant histiocytic disorders
Nexpovio
Selinexor
2021-03-26
2032-2035
Multiple myeloma
Orserdu
Elacestrant
2023-01-27
2024-2038
Breast neoplasms
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
TAGRAXOFUSP
myelodysplastic syndromes
,
myeloid leukemia acute
,
leukemia
,
blastic plasmacytoid dendritic cell neoplasm
,
multiple myeloma
,
plasma cell neoplasms
,
primary myelofibrosis
,
myelomonocytic leukemia chronic
,
myelomonocytic leukemia acute
,
myelomonocytic leukemia juvenile
,
myeloid leukemia
,
pathologic complete response
,
hematologic neoplasms
,
residual neoplasm
Elacestrant
non-small-cell lung carcinoma
,
liver diseases
,
hepatic insufficiency
,
brain neoplasms
,
hot flashes
,
neoplasms
,
central nervous system neoplasms
,
central nervous system diseases
,
brain diseases
,
neoplasms by site
,
breast diseases
,
intraductal carcinoma noninfiltrating
,
neoplasm metastasis
,
hereditary breast and ovarian cancer syndrome
,
radiotherapy
,
recurrence
,
endometrial neoplasms
,
breast neoplasms
,
triple negative breast neoplasms
,
male breast neoplasms
,
ventricular tachycardia
,
tachycardia
,
healthy volunteers/patients
Cilmostim
fallopian tube neoplasms
,
ovarian epithelial carcinoma
,
t-cell lymphoma peripheral
Regramostim
precursor cell lymphoblastic leukemia-lymphoma
,
lymphoid leukemia
,
lymphoma
,
mantle-cell lymphoma
,
non-hodgkin lymphoma
,
leukemia
,
bcr-abl positive chronic myelogenous leukemia
,
myeloid leukemia chronic-phase
,
myeloid leukemia acute
,
myeloid leukemia
Molgramostim
neoplasms
,
hodgkin disease
,
myelodysplastic syndromes
,
neutropenia
,
chemotherapy-induced febrile neutropenia
,
healthy volunteers/patients
Lysine
pheochromocytoma
,
paraganglioma
,
neuroendocrine tumors
,
pancreatic neoplasms
,
stomach neoplasms
,
intestinal neoplasms
Carboxymethylcellulose
lipodystrophy
,
hiv-associated lipodystrophy syndrome
,
ulcerative colitis
,
colitis
,
ulcer
,
hiv infections
,
infections
,
acquired immunodeficiency syndrome
,
hepatitis b
,
chronic hepatitis b
,
hepatitis
,
chronic hepatitis
,
hepatitis a
Bevifimod
phenylketonurias
FELEZONEXOR
neoplasms
Nepidermin
pancreatic neoplasms
,
chronic hepatitis c
Globulin, immune
prostatic neoplasms
,
small cell carcinoma
,
neuroendocrine tumors
Krestin
neoplasms
,
hodgkin disease
,
neutropenia
,
myelodysplastic syndromes
,
healthy volunteers/patients
Endocrine
castration-resistant prostatic neoplasms
,
non-small-cell lung carcinoma
,
healthy volunteers/patients
,
ovarian neoplasms
,
triple negative breast neoplasms
,
liposarcoma
,
colorectal neoplasms
,
adenocarcinoma of lung
,
fallopian tube neoplasms
,
ovarian epithelial carcinoma
,
neoplasms
,
prostatic neoplasms
,
recurrence
,
type 2 diabetes mellitus
,
male breast neoplasms
,
endocrine system diseases
,
diabetes mellitus
,
unilateral breast neoplasms
,
neoplasm metastasis
,
obesity
,
glucose metabolism disorders
,
metabolic diseases
,
body weight
,
overweight
,
nutrition disorders
,
signs and symptoms
,
nutritional and metabolic diseases
,
signs and symptoms pathological conditions
,
overnutrition
,
breast neoplasms
,
acromegaly
,
left ventricular hypertrophy
,
left ventricular dysfunction
,
laron syndrome
,
pituitary dwarfism
,
bipolar disorder
,
coronary disease
,
coronary artery disease
Hiltonol
plasma cell neoplasms
,
smoldering multiple myeloma
Pd0332991
neoplasms
,
non-hodgkin lymphoma
,
multiple myeloma
,
neoplasm metastasis
,
ovarian neoplasms
,
breast neoplasms
,
triple negative breast neoplasms
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use